Veranova appoints Thomas Rohrer as vice president of bioconjugation Veranova appoints Thomas Rohrer as vice president of bioconjugation Industry veteran to lead expanding cGMP capabilities for ADC and bioconjugate development Galapagos appoints Dawn Svoronos and Jane Griffiths to board of directors Galapagos appoints Dawn Svoronos and Jane Griffiths to board of directors New independent directors bring decades of commercial and strategic biopharma expertise Galapagos appoints new business and strategy leaders to support transformation Galapagos appoints new business and strategy leaders to support transformation Life sciences veterans join management committee to advance growth and shareholder value Abzena appoints Geoffrey M. Glass as Chief Executive Officer Abzena appoints Geoffrey M. Glass as Chief Executive Officer Geoffrey M. Glass has been appointed Chief Executive Officer (CEO), effective immediately. Mr. Glass has served as Chairman of the Board since 2022 Quotient Sciences announces formation of scientific advisory board Quotient Sciences announces formation of scientific advisory board Advisory board will contribute to driving innovation and technology aligned with Company strategic priorities ACG strengthens its engineering leadership with appointment of Nikhil Kulkarni as CEO ACG strengthens its engineering leadership with appointment of Nikhil Kulkarni as CEO Based out of the company’s office in Pune, Nikhil will lead the strategic direction and operations of its engineering division ONWARD Medical adds Tim Denison, PhD to its Board of Directors ONWARD Medical adds Tim Denison, PhD to its Board of Directors Professor Tim Denison has been appointed to the Board of Directors and will assume the Board seat previously held by Professor Gregoire Courtine Neopac appoints new Chief Sales Officer to strengthen global sales growth Neopac appoints new Chief Sales Officer to strengthen global sales growth Industry veteran Bernd Steiner joins Executive Management Team, will lead international sales strategy Ingenza appoints Nick Challoner as Chief Executive Officer Ingenza appoints Nick Challoner as Chief Executive Officer Nick brings over 30 years of experience in business leadership, innovation, and commercial strategy and execution across the chemical and biotechnology sectors Veranova appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides Veranova appoints Dr. Matteo Villain as Vice President of Peptides and Oligonucleotides Dr. Villain will bring extensive expertise in peptide and oligonucleotide development and manufacturing to Veranova as the company continues to strengthen its position as a key... Symbiosis appoints Angelika Rublack as Senior Business Development Manager Symbiosis appoints Angelika Rublack as Senior Business Development Manager Symbiosis expands global reach with key appointment of Angelika Rublack as Senior Business Development Manager Leon-nanodrugs appoints new CEO to lead commercialisation of nanoparticle manufacturing systems Leon-nanodrugs appoints new CEO to lead commercialisation of nanoparticle manufacturing systems Dr. Wolfgang Hofmann to guide LEON through its transition from development to market ten23 health forms intergenerational advisory board to boost CSR ten23 health forms intergenerational advisory board to boost CSR New board reinforces focus on patients, people, and planet Abzena announces establishment of Scientific Advisory Board to support innovation strategy Abzena announces establishment of Scientific Advisory Board to support innovation strategy The new advisory board will work closely with Abzena’s scientific and commercial leadership to provide strategic guidance and expert insights that support Abzena’s... Prolific Machines appoints former Catalent CSO to Board of Directors Prolific Machines appoints former Catalent CSO to Board of Directors Expert appointment further accelerates Prolific’s ability to deliver impactful protein production solutions as it prepares to expand its light-controlled bioproduction offerings Lonza appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer Lonza appoints Andreas Bohrer as Chief Legal & Corporate Affairs Officer As of 1 July 2025, Andreas joins Lonza’s Executive Committee as Chief Legal & Corporate Affairs Officer